Elevated admission microalbuminuria predicts poor myocardial blood flow and 6-month mortality in st-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention Full Text
Clinical Cardiology, 04/25/2012
Chen JW et al. – Admission microalbuminuria (MA) levels are associated with impaired myocardial flow and poor prognosis in ST–segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI).



